BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32153729)

  • 1. Deep graph embedding for prioritizing synergistic anticancer drug combinations.
    Jiang P; Huang S; Fu Z; Sun Z; Lakowski TM; Hu P
    Comput Struct Biotechnol J; 2020; 18():427-438. PubMed ID: 32153729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRODeepSyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein-protein interaction network.
    Wang X; Zhu H; Jiang Y; Li Y; Tang C; Chen X; Li Y; Liu Q; Liu Q
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35043159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Drug Synergy and Discovering New Drug Combinations Based on a Graph Autoencoder and Convolutional Neural Network.
    Li H; Zou L; Kowah JAH; He D; Wang L; Yuan M; Liu X
    Interdiscip Sci; 2023 Jun; 15(2):316-330. PubMed ID: 36943614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graph-DTI: A New Model for Drug-Target Interaction Prediction Based on Heterogenous Network Graph Embedding.
    Qu X; Du G; Hu J; Cai Y
    Curr Comput Aided Drug Des; 2023 Jul; ():. PubMed ID: 37448360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DTiGNN: Learning drug-target embedding from a heterogeneous biological network based on a two-level attention-based graph neural network.
    Muniyappan S; Rayan AXA; Varrieth GT
    Math Biosci Eng; 2023 Mar; 20(5):9530-9571. PubMed ID: 37161255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning-based multi-drug synergy prediction model for individually tailored anti-cancer therapies.
    She S; Chen H; Ji W; Sun M; Cheng J; Rui M; Feng C
    Front Pharmacol; 2022; 13():1032875. PubMed ID: 36588694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSCGCN: A novel deep GCN model to diagnosis COVID-19.
    Tang C; Hu C; Sun J; Wang SH; Zhang YD
    Comput Biol Med; 2022 Nov; 150():106151. PubMed ID: 36244303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations.
    Wang J; Liu X; Shen S; Deng L; Liu H
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34571537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DTF: Deep Tensor Factorization for predicting anticancer drug synergy.
    Sun Z; Huang S; Jiang P; Hu P
    Bioinformatics; 2020 Aug; 36(16):4483-4489. PubMed ID: 32369563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GraphSynergy: a network-inspired deep learning model for anticancer drug combination prediction.
    Yang J; Xu Z; Wu WKK; Chu Q; Zhang Q
    J Am Med Inform Assoc; 2021 Oct; 28(11):2336-2345. PubMed ID: 34472609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlocking the therapeutic potential of drug combinations through synergy prediction using graph transformer networks.
    Alam W; Tayara H; Chong KT
    Comput Biol Med; 2024 Mar; 170():108007. PubMed ID: 38242015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cell line-specific synergistic drug combinations through a relational graph convolutional network with attention mechanism.
    Zhang P; Tu S; Zhang W; Xu L
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36136353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAMF-GCN: Multi-scale adaptive multi-channel fusion deep graph convolutional network for predicting mental disorder.
    Pan J; Lin H; Dong Y; Wang Y; Ji Y
    Comput Biol Med; 2022 Sep; 148():105823. PubMed ID: 35872410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MVS-GCN: A prior brain structure learning-guided multi-view graph convolution network for autism spectrum disorder diagnosis.
    Wen G; Cao P; Bao H; Yang W; Zheng T; Zaiane O
    Comput Biol Med; 2022 Mar; 142():105239. PubMed ID: 35066446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hi-GCN: A hierarchical graph convolution network for graph embedding learning of brain network and brain disorders prediction.
    Jiang H; Cao P; Xu M; Yang J; Zaiane O
    Comput Biol Med; 2020 Dec; 127():104096. PubMed ID: 33166800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GADTI: Graph Autoencoder Approach for DTI Prediction From Heterogeneous Network.
    Liu Z; Chen Q; Lan W; Pan H; Hao X; Pan S
    Front Genet; 2021; 12():650821. PubMed ID: 33912218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRSPRING: Graph convolutional network (GCN)-Based drug synergy prediction utilizing drug-induced gene expression profile.
    Han J; Kang MJ; Lee S
    Comput Biol Med; 2024 May; 174():108436. PubMed ID: 38643597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DTI-HETA: prediction of drug-target interactions based on GCN and GAT on heterogeneous graph.
    Shao K; Zhang Y; Wen Y; Zhang Z; He S; Bo X
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35380622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AttenSyn: An Attention-Based Deep Graph Neural Network for Anticancer Synergistic Drug Combination Prediction.
    Wang T; Wang R; Wei L
    J Chem Inf Model; 2024 Apr; 64(7):2854-2862. PubMed ID: 37565997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GCNGAT: Drug-disease association prediction based on graph convolution neural network and graph attention network.
    Yang R; Fu Y; Zhang Q; Zhang L
    Artif Intell Med; 2024 Apr; 150():102805. PubMed ID: 38553169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.